Finance

Lists
500087:BOM
Cipla Ltd
1 313,70 ₹
+0,80%
(+10,40) 1D
12 қаз., 15:57:14 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500087...
Open
1 305,00 ₹
High
1 316,50 ₹
Low
1 300,25 ₹
Mkt. cap
1,06 трлн
Avg. vol.
43,53 мың
Volume
43,36 мың
Dividend
0,99%
Quarterly dividend
3,25 ₹
Ex-dividend date
2026 ж. 05 мау.
P/E ratio
31,50
52-wk high
1 672,20 ₹
52-wk low
1 165,55 ₹
EPS
41,70 ₹
Shares outstanding
805,67 млн
No. of employees
31 мың
Open
1 305,00 ₹
High
1 316,50 ₹
Low
1 300,25 ₹
Mkt. cap
1,06 трлн
Avg. vol.
43,53 мың
Volume
43,36 мың
Dividend
0,99%
Quarterly dividend
3,25 ₹
Ex-dividend date
2026 ж. 05 мау.
P/E ratio
31,50
52-wk high
1 672,20 ₹
52-wk low
1 165,55 ₹
EPS
41,70 ₹
Shares outstanding
805,67 млн
No. of employees
31 мың
News stories
From web sources and news partners
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31,4 мың
Founded1935
HeadquartersМумбаи, Махараштра, Үндістан
SectorPharmaceutical industry
Websitecipla.com
Last report
2026 ж. 23 шіл.
Fiscal period
Q1 2027
9,76 ₹ / 10,42 ₹
-6,36%miss
Revenue / Est. (INR)
70,77 млрд / 71,42 млрд
-0,91%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
74,47 млрд
69,63 млрд
65,80 млрд
70,77 млрд
Cost of goods sold
24,98 млрд
26,32 млрд
25,10 млрд
26,67 млрд
Cost of revenue
24,98 млрд
26,32 млрд
25,10 млрд
26,67 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,15 млрд
13,25 млрд
28,23 млрд
14,97 млрд
Operating expense
33,52 млрд
33,54 млрд
33,30 млрд
35,22 млрд
Total operating expenses
58,50 млрд
59,86 млрд
58,39 млрд
61,89 млрд
Operating income
15,98 млрд
9,77 млрд
7,41 млрд
8,88 млрд
Other non operating income
2,69 млрд
2,06 млрд
-5,35 млрд
2,11 млрд
EBT including unusual items
18,54 млрд
8,93 млрд
6,99 млрд
10,80 млрд
EBT excluding unusual items
18,54 млрд
11,69 млрд
4,51 млрд
10,80 млрд
Income tax expense
5,00 млрд
2,19 млрд
1,57 млрд
2,95 млрд
Effective tax rate
27,00%
24,48%
22,44%
27,29%
Other operating expenses
17,40 млрд
17,51 млрд
2,51 млрд
17,20 млрд
Net income
13,51 млрд
6,76 млрд
5,55 млрд
7,89 млрд
Net profit margin
18,14%
9,71%
8,43%
11,15%
Earnings per share
16,72
10,94
6,86
9,76
Interest and investment income
-
-
2,07 млрд
-
Interest expense
-131,80 млн
-140,30 млн
-69,70 млн
-170,30 млн
Net interest expenses
-131,80 млн
-140,30 млн
2,00 млрд
-170,30 млн
Depreciation and amortization charges
2,97 млрд
2,78 млрд
2,56 млрд
3,04 млрд
EBITDA
18,73 млрд
12,00 млрд
9,82 млрд
11,29 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары